Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FDG-PET/CT and Ferumoxtran-10 MRI for Lymph Node Metastasis in Cervical and Endometrial Cancer
NCT00416455Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2007
- Primary completion
- Sep 2014
- Modality
- Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of ferumoxtran-10, fludeoxyglucose f 18 in Cervical Cancer (CC), endometrial cancer (EC), sponsored by National Cancer Institute. Started Sep 2007; status: completed.
02
Drugs
ferumoxtran-10fludeoxyglucose f 18
03
Conditions
Cervical Cancer (CC)endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00416455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00416455.